Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 13,544,000 | 12,504,000 | 11,306,000 | 10,021,400 | 8,281,300 |
| Cost of Goods | 2,094,000 | 2,274,000 | 2,176,000 | 2,164,100 | 1,918,600 |
| Gross Profit | 11,450,000 | 10,230,000 | 9,130,000 | 7,857,300 | 6,362,700 |
| Operating Expenses | 7,847,000 | 6,884,000 | 6,326,000 | 5,558,200 | 4,390,800 |
| Operating Income | 3,603,000 | 3,346,000 | 2,804,000 | 2,299,200 | 1,972,500 |
| Interest Expense | 0 | 0 | 0 | 0 | 126,900 |
| Other Income | -1,009,000 | -258,000 | 0 | 0 | 15,900 |
| Pre-tax Income | 2,594,000 | 3,088,000 | 2,804,000 | 2,299,200 | 1,861,500 |
| Income Tax | 642,000 | 865,000 | 869,000 | 738,000 | 558,500 |
| Net Income Continuous | 2,630,000 | 2,082,000 | 1,929,000 | 1,551,600 | 1,298,400 |
| Net Income Discontinuous | 1,401,000 | 0 | 0 | 18,700 | 0 |
| Net Income | $3,351,000 | $2,213,000 | $1,929,000 | $1,572,900 | $1,298,400 |
| EPS Basic Total Ops | 0.88 | 0.59 | 0.50 | 0.42 | 0.35 |
| EPS Basic Continuous Ops | 0.69 | 0.55 | 0.50 | 0.41 | 0.35 |
| EPS Basic Discontinuous Ops | 0.37 | N/A | N/A | 0.01 | N/A |
| EPS Diluted Total Ops | 0.49 | 0.57 | 0.50 | 0.42 | 0.35 |
| EPS Diluted Continuous Ops | 0.67 | 0.53 | 0.50 | 0.41 | 0.35 |
| EPS Diluted Discontinuous Ops | 0.36 | N/A | N/A | 0.01 | N/A |
| EBITDA(a) | $4,092,000 | $3,848,000 | $3,234,000 | $2,673,200 | $2,264,500 |